Michelle L. Mellion

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Noel Donnelly, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michelle L. Mellion:

Company Role Class Num Shares Value Price $ Report Date Ownership
PepGen Inc. Chief Medical Officer Common Stock 0 $0 $18.06 25 Jul 2024 Direct
PepGen Inc. Chief Medical Officer Stock Option (Right to Buy) 50,000 25 Jul 2024 Direct

Insider Reports Filed by Michelle L. Mellion

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PEPG PepGen Inc. 24 Jul 2024 6 -$61,008 4 Chief Medical Officer 26 Jul 2024, 16:52
PEPG PepGen Inc. 18 Jul 2024 3 -$100,903 4 Chief Medical Officer 19 Jul 2024, 16:09
PEPG PepGen Inc. 12 Jul 2024 6 -$71,759 4 Chief Medical Officer 16 Jul 2024, 16:46
PEPG PepGen Inc. 01 Jul 2024 6 -$7,117 4 Chief Medical Officer 03 Jul 2024, 13:12
PEPG PepGen Inc. 24 Jun 2024 3 -$73,883 4 Chief Medical Officer 26 Jun 2024, 16:26
PEPG PepGen Inc. 11 Jun 2024 6 -$12,444 4 Chief Medical Officer 13 Jun 2024, 16:46
PEPG PepGen Inc. 05 Jun 2024 6 -$68,082 4 SVP, Clinical Development 07 Jun 2024, 16:12
PEPG PepGen Inc. 01 Mar 2024 1 $0 4 SVP, Clinical Development 01 Mar 2024, 17:29
PEPG PepGen Inc. 01 Mar 2023 2 $0 4 SVP, Clinical Development 02 Mar 2023, 15:53
PEPG PepGen Inc. 01 Jul 2022 1 $0 4 Sr. VP. Clinical Development 31 Aug 2022, 16:15
PEPG PepGen Inc. 06 May 2022 1 $0 4 Sr. VP. Clinical Development 10 May 2022, 18:53
PEPG PepGen Inc. 05 May 2022 0 $0 3 Sr. VP. Clinical Development Exhibit 24: Power of Attorney 05 May 2022, 20:30